Ascendis Pharma A/S American Depositary Shares
ASND Real Time Price USDRecent trades of ASND by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ASND's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Auto injector with detection of used cartridge and associated method Jun. 11, 2024
-
Patent Title: Auto injector with adaptable air-shot mechanism Apr. 30, 2024
-
Patent Title: Auto injector with reconstitution handling support Apr. 16, 2024
-
Patent Title: Conjugation method for carrier-linked prodrugs Feb. 13, 2024
-
Patent Title: Auto injector with charger safety Aug. 29, 2023
-
Patent Title: Auto injector with variable plunger force Jun. 27, 2023
-
Patent Title: Hydrogel cross-linked hyaluronic acid prodrug compositions and methods May. 09, 2023
-
Patent Title: Prodrugs comprising an aminoalkyl glycine linker Apr. 25, 2023
-
Patent Title: Front loaded auto injector for administering a medicament Mar. 21, 2023
-
Patent Title: Biodegradable polyethylene glycol based water-insoluble hydrogels Jan. 24, 2023
-
Patent Title: Auto injector with cartridge locking system Dec. 13, 2022
-
Patent Title: Auto injector with adaptable air-shot mechanism Dec. 06, 2022
-
Patent Title: Auto injector with charger safety Aug. 09, 2022
-
Patent Title: Auto injector with temperature control Jun. 07, 2022
-
Patent Title: Prodrugs comprising a pyroglutamate linker Apr. 12, 2022
-
Patent Title: Auto injector with detection of used cartridge and associated method Nov. 23, 2021
-
Patent Title: Hydrogel-linked prodrugs releasing tagged drugs Sep. 14, 2021
-
Patent Title: Diagnosis, prevention and treatment of diseases of the joint Apr. 20, 2021
-
Patent Title: Injector Jan. 12, 2021
-
Patent Title: Auto injector with cartridge retention system Nov. 17, 2020
-
Patent Title: Carrier-linked treprostinil prodrugs Aug. 04, 2020
-
Patent Title: Hydrogel-linked prodrugs releasing tagged drugs May. 19, 2020
-
Patent Title: Protecting group comprising a purification tag Aug. 07, 2018
-
Patent Title: Hydrogel formulations Jul. 24, 2018
-
Patent Title: Carrier-linked prostanoid prodrugs Mar. 13, 2018
-
Patent Title: Sustained release composition of prostacyclin Jan. 23, 2018
-
Patent Title: Hydrogel prodrugs Jan. 02, 2018
-
Patent Title: Carrier-linked treprostinil prodrugs Feb. 07, 2017
-
Patent Title: Carrier-linked carbamate prodrug linkers Feb. 07, 2017
-
Patent Title: Dipeptide-based prodrug linkers for aliphatic amine-containing drugs Jan. 03, 2017
-
Patent Title: Sterilization of biodegradable hydrogels Mar. 08, 2016
-
Patent Title: Prodrugs containing an aromatic amine connected by an amido bond to a linker Nov. 03, 2015
-
Patent Title: Dipeptide-based prodrug linkers for aliphatic amine-containing drugs Jun. 23, 2015
-
Patent Title: Hydrogel formulations Jun. 16, 2015
-
Patent Title: Sterilization of biodegradable hydrogels Mar. 24, 2015
-
Patent Title: Prodrug comprising a drug linker conjugate Dec. 09, 2014
-
Patent Title: Subcutaneous paliperidone composition Jun. 24, 2014
-
Patent Title: Hydrogel formulations Jun. 28, 2011
-
Patent Title: Protein-proteophore complexes Feb. 01, 2011
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of ASND in WallStreetBets Daily Discussion
Recent insights relating to ASND
Recent picks made for ASND stock on CNBC
ETFs with the largest estimated holdings in ASND
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ASND Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.